Over the past year there have been some interesting and significant ad
vances in computer-based ligand-protein docking techniques and related
rational drug-design tools, including flexible ligand docking and bet
ter estimation of binding free energies and solvation energies. As a r
esult, the successful use of computational tools to help generate inte
resting new guide (lead) compounds for targeted receptors is becoming
more commonplace.